1. Home
  2. VUZI vs XGN Comparison

VUZI vs XGN Comparison

Compare VUZI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vuzix Corporation

VUZI

Vuzix Corporation

HOLD

Current Price

$2.55

Market Cap

217.9M

Sector

Technology

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$7.10

Market Cap

110.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VUZI
XGN
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.9M
110.7M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
VUZI
XGN
Price
$2.55
$7.10
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
971.9K
261.5K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$6,280,611.00
N/A
Revenue This Year
$103.32
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
9.14
N/A
52 Week Low
$1.97
$2.59
52 Week High
$5.62
$12.23

Technical Indicators

Market Signals
Indicator
VUZI
XGN
Relative Strength Index (RSI) 46.06 51.76
Support Level $2.28 $4.08
Resistance Level $2.76 $7.99
Average True Range (ATR) 0.12 0.38
MACD -0.03 -0.13
Stochastic Oscillator 22.92 3.84

Price Performance

Historical Comparison
VUZI
XGN

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices and third-party original design manufacturer (ODM) and original equipment manufacturer (OEM) devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: